1kjc
From Proteopedia
(Difference between revisions)
m (Protected "1kjc" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | + | ==THEORETICAL MODEL OF THE HUMAN CD6 LIGAND ALCAM (ACTIVATED LEUKOCYTE-CELL ADHESION MOLECULE), N-TERMINAL RECEPTOR- BINDING DOMAIN== | |
+ | <StructureSection load='1kjc' size='340' side='right' caption='[[1kjc]]' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1KJC FirstGlance]. <br> | ||
+ | </td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1kjc FirstGlance], [http://www.ebi.ac.uk/pdbsum/1kjc PDBsum]</span></td></tr> | ||
+ | <table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | CD6-ligand interactions have been implicated in the regulation of T-cell adhesion and activation. CD6 is a member of the scavenger receptor family, whereas its human ligand (ALCAM) belongs to the immunoglobulin superfamily. The extracellular region of ALCAM includes five immunoglobulin-like domains. As a fusion protein, the N-terminal extracellular domain of ALCAM (ALCAMD1) binds specifically to CD6. We report the construction, assessment, and analysis of a molecular model of ALCAMD1. The model defines the CDR-analogous loops, the location of N-linked glycosylation sites, and residues that form the beta-sheet faces of the immunoglobulin-like domain. Predicted structural characteristics of the A'GFCC'C" face of the model are consistent with the presence of monomeric and dimeric forms of ALCAMD1, which has implications for the receptor-ligand interactions. | ||
- | + | Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM.,Bajorath J, Bowen MA, Aruffo A Protein Sci. 1995 Aug;4(8):1644-7. PMID:8520490<ref>PMID:8520490</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | == References == | |
- | + | <references/> | |
- | + | __TOC__ | |
- | + | </StructureSection> | |
- | == | + | |
- | < | + | |
[[Category: Aruffo, A]] | [[Category: Aruffo, A]] | ||
[[Category: Bajorath, J]] | [[Category: Bajorath, J]] | ||
[[Category: Bowen, M A]] | [[Category: Bowen, M A]] |
Revision as of 10:49, 28 September 2014
THEORETICAL MODEL OF THE HUMAN CD6 LIGAND ALCAM (ACTIVATED LEUKOCYTE-CELL ADHESION MOLECULE), N-TERMINAL RECEPTOR- BINDING DOMAIN
|